与多个系统缩的吸收风险相关的临床措施:一个横截面研究
Jun Tanimura1,2, Toshiyuki Yamamoto1, Yuji Takahashi1
1Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry (NCNP), 4-1-1 Ogawa Higashicho, Kodaira, Tokyo 187-8502, Japan.
Clinical parkinsonism & related disorders
|November 10, 2025
概括
巴特尔指数 (BI) 可以帮助识别多重系统缩 (MSA) 患者的吸收风险,特别是那些患有帕金森亚型的患者. 这种测量可以指导吞评估,即使没有明显的吞障碍症状.
科学领域:
- 神经学 神经学
- 吞障碍 吞障碍 吞障碍
- 临床诊断 临床诊断 临床诊断
背景情况:
- 吸收风险是多系统性缩 (MSA) 管理中的一个关键问题.
- 识别可靠的临床标志物吸收对于及时干预至关重要.
研究的目的:
- 调查基本临床测量 (巴特尔指数,UMSARS,DaT成像) 与MSA患者的吸收风险之间的关联.
- 评估这些措施在识别志向方面的歧视能力.
主要方法:
- 对105名MSA患者进行的横截面研究,这些患者接受了视频光学吞检查 (VF) 和DaT成像.
- 在VF的3个月内评估的临床措施 (BI,UMSARS).
- 用于评估关联和区分能力的多变量修改的波桑回归和ROC分析.
主要成果:
- 26.7%的MSA患者在VF上表现出渴望.
- 较低的BI和较高的UMSARS分数与愿望有显著的关联.
- 比尔表现出适度的吸收区分能力 (AUC 0.77),特别是在帕金森MSA亚型中.
结论:
- 巴特尔指数 (BI) 显示了其作为MSA中吸收风险的临床标志物的潜力.
- BI可能有助于指导吞评估,特别是在帕金森MSA亚型中,即使是微妙的吞障碍.
- 这些发现可以为MSA患者护理的临床决策提供信息.
相关概念视频
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Assessment of Airway, Skin Color, and Use of Accessory Muscles
1.6K
A thorough assessment of respiratory health is paramount in clinical settings to identify and manage respiratory distress and ensure adequate oxygenation. This article elaborates on the critical aspects of respiratory evaluation, including airway assessment, skin color examination, and the observation of accessory muscle use, which are integral to effectively diagnosing and managing patients with respiratory conditions.
Introduction
The initial evaluation of a patient's respiratory system...
Introduction
The initial evaluation of a patient's respiratory system...
1.6K
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
3.1K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
3.1K
Mitral Stenosis II: Clinical features and Diagnostic Tests
206
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
206


